Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis
Status:
Terminated
Trial end date:
2018-09-10
Target enrollment:
Participant gender:
Summary
Single centre, double-blind, placebo controlled, adaptive design, cross-over trial. The
primary objective is to assess the additive effects of using combined intranasal fluticasone
propionate plus azelastine nasal spray on airway hyperresponsiveness. This is in patients
with persistent asthma and allergic rhinitis, receiving inhaled steroid.